Inventor · disambiguated record
Jeffrey Paul Stonehouse
Also filed as: STONEHOUSE JEFFREY · STONEHOUSE JEFFREY PAUL
9 granted patents·7 pending applications·39 citations·filing 2003–2021
87Inventor score
Files withASTRAZENECA AB9CHESHIRE DAVID RANULF3MEGHANI PREMJI2CHESHIRE DAVID1GULLBERG BRITT ANNE INGELA1
Top patents by PatentIndex Score
16 records- 0190US7838675B2Pyrimidine sulphonamide derivatives as chemokine receptor modulatorsASTRAZENECA AB·Filed 2005·Granted Nov 23, 2010·13 cites·6 claims
- 0285US11000525B21-[2-(aminomethyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-ones as inhibitors of myeloperoxidaseASTRAZENECA AB·Filed 2018·Granted May 11, 2021·2 cites·2 claims
- 0384US10016430B21-[2-(aminomethyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-ones as inhibitors of myeloperoxidaseASTRAZENECA AB·Filed 2017·Granted Jul 10, 2018·5 cites·4 claims
- 0483US9616063B21-[2-(aminomethyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-ones as inhibitors of myeloperoxidaseASTRAZENECA AB·Filed 2015·Granted Apr 11, 2017·4 cites·12 claims
- 0582US8269002B2Pyrimidine sulphonamide derivatives as chemokine receptor modulatorsCHESHIRE DAVID RANULF·Filed 2010·Granted Sep 18, 2012·7 cites·11 claims
- 0681US8410123B2Pyrimidine sulphonamide derivatives as chemokine receptor modulatorsCHESHIRE DAVID RANULF·Filed 2011·Granted Apr 2, 2013·6 cites·2 claims
- 0772US11975004B21-[2-(aminomethyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-ones as inhibitors of myeloperoxidaseASTRAZENECA AB·Filed 2021·Granted May 7, 2024·0 cites·4 claims
- 0863US8748603B2Crystalline forms of N-[2-[[(2,3-difluorophenyl)methyl]THIO]-6-{[(1R,2S)-2,3-dihydroxy-1-methylpropyl]oxy}-4-pyrimidinyl]-1-azetidinesulfonamideGULLBERG BRITT ANNE INGELA·Filed 2011·Granted Jun 10, 2014·2 cites·7 claims
- 0961US8722883B2Pyrimidine sulphonamide derivatives as chemokine receptor modulatorsASTRAZENECA AB·Filed 2013·Granted May 13, 2014·0 cites·1 claims
- 1054US2013012490A1Pyrimidine Sulphonamide Derivatives as Chemokine Receptor ModulatorsCHESHIRE DAVID RANULF·Filed 2012·Application pending·0 cites
- 1146US2014235606A1Crystalline forms of n-[2-[[(2,3-difluorophenyl)methyl]thio]-6--4-pyrimidinyl]-1-azetidinesulfonamideASTRAZENECA AB·Filed 2014·Application pending·0 cites
- 1245US2006270714A1Novel n-substituted 2-aminopyridine derivativesCHESHIRE DAVID·Filed 2004·Application pending·0 cites
- 1343US2010016275A1Novel compound 395MEGHANI PREMJI·Filed 2009·Application pending·0 cites
- 1443US2006040992A1Antiinflammatory 3-arylthio-3-thiazolyl-alkylaminesASTRAZENECA AB·Filed 2003·Application pending·0 cites
- 1541US2009192134A1CompoundsMEGHANI PREMJI·Filed 2005·Application pending·0 cites
- 1641US2009239882A1Thiazolopyramidine Compounds for the Modulation of Chemokine Receptor ActivityASTRAZENECA AB·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeffrey Paul Stonehouse files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →